A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
Top Cited Papers
- 9 November 2004
- journal article
- clinical trial
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 2 (12) , 1107-1115
- https://doi.org/10.1016/s1542-3565(04)00457-4
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis† ‡Hepatology, 2004
- Obesity, Insulin Resistance, and Cardiovascular DiseaseRecent Progress in Hormone Research, 2004
- Pioglitazone, a Peroxisome Proliferator-Activated Receptor-γ Agonist, Attenuates Myocardial Ischemia/Reperfusion Injury in a Rat ModelLaboratory Investigation, 2003
- Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazoneHepatology, 2003
- Voies de signalisation de l’insuline : mécanismes affectés dans l’insulino-résistancemédecine/sciences, 2003
- Clinical and Histologic Spectrum of Nonalcoholic Fatty Liver Disease Associated With Normal Alt ValuesHepatology, 2003
- Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline‐deficient dietJournal of Cellular and Molecular Medicine, 2002
- Vitamin E treatment of nonalcoholic steatohepatitis in children: A pilot studyThe Journal of Pediatrics, 2000
- Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆Gastroenterology, 1999
- Pathophysiology and Pathogenesis of Visceral Fat ObesityAnnals of the New York Academy of Sciences, 1994